The Latest Breaking News from FDA

Rishi Sunak is said to want a ‘swift conclusion’ to the inquiry into claims of bullying against his deputy

The FDA’s general secretary said allowing the PM to act as ‘judge and jury’ was not a suitable way of dealing with civil service allegations.

The Prime Minister received the report into whether his deputy bullied civil servants on Thursday morning.

The Supreme Court has given itself until midnight Friday to make an “emergency” decision on access to mifepristone, a drug used in half of all U.S. abortions. Whatever the outcome, it’s just a preliminary round in the battle over U.S. District Court Judge Matthew Kacsmaryk’s ruling earlier this month to…

WASHINGTON — On the day the Supreme Court overturned Roe v. Wade, and with it the constitutional right to an abortion, Sen. Josh Hawley was thrilled.

The nation’s highest court will weigh in on a challenge to the FDA’s approval of the drug

Plus: The EARN IT Act is back (again), SCOTUS postpones abortion pill decision until Friday, and more...

Messages showing Antioch officers using racist slurs, and bragging about making up evidence and beating suspects have sparked outrage. Plus, supreme court delays decision on abortion pill restrictions

The Supreme Court initially gave itself a deadline of Wednesday to decide whether women seeking access to a widely used abortion pill would face more restrictions while a court case plays out

Mifepristone is currently used to treat a handful of conditions, including Cushing’s syndrome. A suspension would affect more than those seeking medication abortions.

Another COVID-19 booster shot is on the way as federal health officials look to further augment protection for those at greater risk of developing severe disease.